Denali Therapeutics Inc.
FUSION PROTEINS COMPRISING PROGRANULIN
Last updated:
Abstract:
Provided herein are fusion proteins that comprise progranulin and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein.
Status:
Application
Type:
Utility
Filling date:
18 Jun 2019
Issue date:
16 Sep 2021